P.O. Box 959
339 articles with AmerisourceBergen Corporation
AmerisourceBergen Expands Commitment to Diversity and Inclusion as a Company Priority with Appointment of New SVP and Chief Diversity & Inclusion Officer, Dr. Lonie Haynes
As part of its commitment to fostering a diverse and inclusive culture, AmerisourceBergen, a global healthcare solutions leader, announced the appointment of Dr. Lonie Haynes as the company’s SVP and Chief Diversity & Inclusion Officer.
AmerisourceBergen Reaches Agreement with U. S. Centers for Disease Control and Prevention to Support Independent Retail Pharmacies’ Access to COVID-19 Vaccine
AmerisourceBergen Reaches Agreement with U. S. Centers for Disease Control and Prevention to Support Independent Retail Pharmacies’ Access to COVID-19 Vaccine VALLEY FORGE, Pa.--( BUSINESS WIRE )-- AmerisourceBergen has reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC) to include Good Neighbor Pharmacy and Elevate Provider Network members in the Federal Pharmacy Partnership Strategy for COVID-19 Vaccination. To suppo
AmerisourceBergen Corporation reported that in its fiscal year 2020 fourth quarter ended September 30, 2020, revenue increased 7.9 percent to $49.2 billion.
ION & IPN Solutions Collaborate with Annexus Health to Offer AssistPoint to Specialty Physician Practices
The connected workflow platform helps specialty practices manage the financial assistance process in a comprehensive, yet streamlined way
The annual event, which convenes thousands of independent community pharmacies, moves to an immersive virtual environment on AmerisourceBergenLive.com
AmerisourceBergen Corporation reported that in its fiscal year 2020 third quarter ended June 30, 2020, revenue increased 0.3 percent year-over-year to $45.4 billion.
Two flexible financing solutions make essential pet care more affordable in the wake of COVID-19
AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter Fiscal 2020 on Wednesday, August 5, 2020, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 5, 2020. Participating in the conference call will be: Steven H. Collis, Chairman, President & Ch
AmerisourceBergen, a global healthcare solutions leader, announced today that it has been selected by Deciphera Pharmaceuticals (Deciphera) to support QINLOCK (ripretinib). AmerisourceBergen is providing a unified commercialization approach for QINLOCK which was approved by the U.S. Food and Drug Administration (FDA) on Friday, May 15, 2020. QINLOCK is an orally administered kinase switch control inhibitor approved for
AmerisourceBergen Corporation announced the closing of its public offering of $500 million aggregate principal amount of its 2.800% Senior Notes due May 15, 2030, in an underwritten registered public offering.
AmerisourceBergen Corporation reported that in its fiscal year 2020 second quarter ended March 31, 2020, revenue increased 9.5 percent to $47.4 billion.
AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter Fiscal 2020 on Thursday, May 7, 2020, prior to the opening of trading on the New York Stock Exchange.
Report Highlights Excellence in Promoting Sustainable Operations, Inspiring Associates and Supporting Healthy Communities
Today, global healthcare solutions leader AmerisourceBergen announced that it is continuing its strategic relationship with the American Oncology Network, LLC (AON), a high-growth medical oncology provider with a focus on supporting the long-term viability of oncology treatment in community-based settings. AmerisourceBergen will support AON in its effort to accelerate key strategic priorities to scale its integrated value-based care delivery model nationwide.
The Quell Foundation Receives Grant from the AmerisourceBergen Foundation for Lift the Mask Documentary
The Quell Foundation is proud to announce that it received a grant from the AmerisourceBergen Foundation, an independent not-for-profit charitable giving organization focused on supporting health-related causes that enrich the global community.
AmerisourceBergen Foundation Supports 25+ Organizations to Increase Access to Mental Health Services and Prescription Drug Safety Education
Feb. 12, 2020 13:30 UTC Community Non-Profits Receive Funding for Youth and Family Programming; Provider Support; and Learning Development VALLEY FORGE, Pa.--( BUSINESS WIRE )-- The AmerisourceBergen Foundation, an independent not-for-profit charitable giving organization dedicated to supporting health-related causes, announced today it has presented more than 25 organizations – including ten returning partners – with grants to support initiatives related to prescription d
As part of its continued commitment to strengthening specialty physician practices, AmerisourceBergen today announced that it is launching expanded offerings to specialty physician practices through IPN Solutions.
AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2020 first quarter ended December 31, 2019, revenue increased 5.4 percent to $47.9 billion.
The Company will host a conference call to discuss the results at 8:30 a.m. ET on January 30, 2020.
Implementing the Program in Collaboration with US Bioservices, an AmerisourceBergen Specialty Pharmacy, Will Drive Increased Compliance with Clinicians Recommended Treatment Programs and Provides an Unprecedented Resource for Patients with Sickle Cell Disease